Dr Reddy’s Q3 profit dips 14 pc on weak US sales
Dr Reddy’s Laboratories reported a 14 per cent decline in consolidated profit after tax at Rs 1,210 crore for the December 2025 quarter, impacted by weaker sales in the US and price erosion in key products.
Espace publicitaire · 300×250